News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,528 Results
Type
Article (87431)
Company Profile (739)
Press Release (770341)
Multimedia
Podcasts (198)
Webinars (29)
Section
Business (232774)
Career Advice (4144)
Deals (39874)
Drug Delivery (144)
Drug Development (91184)
Employer Resources (205)
FDA (18257)
Job Trends (17424)
News (396867)
Policy (39845)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3002)
Academic (1)
Accelerated approval (31)
Adcomms (30)
Allergies (123)
Alliances (56794)
ALS (155)
Alzheimer's disease (1754)
Antibody-drug conjugate (ADC) (313)
Approvals (18369)
Artificial intelligence (475)
Autoimmune disease (163)
Automation (32)
Bankruptcy (402)
Best Places to Work (12512)
BIOSECURE Act (23)
Biosimilars (205)
Biotechnology (457)
Bladder cancer (145)
Brain cancer (52)
Breast cancer (540)
Cancer (4293)
Cardiovascular disease (302)
Career advice (3568)
Career pathing (41)
CAR-T (293)
CDC (36)
Celiac Disease (1)
Cell therapy (769)
Cervical cancer (29)
Clinical research (76146)
Collaboration (1622)
Company closure (4)
Compensation (1001)
Complete response letters (65)
COVID-19 (2928)
CRISPR (85)
C-suite (749)
Cystic fibrosis (143)
Data (5441)
Decentralized trials (2)
Denatured (73)
Depression (115)
Diabetes (344)
Diagnostics (6984)
Digital health (25)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (260)
Drug pricing (161)
Drug shortages (19)
Duchenne muscular dystrophy (201)
Earnings (98028)
Editorial (57)
Employer branding (25)
Employer resources (174)
Events (132847)
Executive appointments (832)
FDA (20636)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1282)
Gene editing (183)
Generative AI (47)
Gene therapy (609)
GLP-1 (934)
Government (5327)
Grass and pollen (4)
Guidances (276)
Healthcare (20779)
HIV (45)
Huntington's disease (46)
IgA nephropathy (79)
Immunology and inflammation (270)
Immuno-oncology (61)
Indications (83)
Infectious disease (3151)
Inflammatory bowel disease (204)
Inflation Reduction Act (14)
Influenza (98)
Intellectual property (200)
Interviews (816)
IPO (17811)
IRA (45)
Job creations (5198)
Job search strategy (2866)
JPM (67)
Kidney cancer (16)
Labor market (92)
Layoffs (639)
Leadership (37)
Legal (10091)
Liver cancer (87)
Longevity (13)
Lung cancer (588)
Lymphoma (333)
Machine learning (41)
Management (66)
Manufacturing (727)
MASH (160)
Medical device (14425)
Medtech (14455)
Mergers & acquisitions (22751)
Metabolic disorders (1074)
Multiple sclerosis (154)
NASH (22)
Neurodegenerative disease (332)
Neuropsychiatric disorders (80)
Neuroscience (2909)
Neurotech (1)
NextGen: Class of 2026 (7686)
Non-profit (5080)
Now hiring (66)
Obesity (526)
Opinion (326)
Ovarian cancer (151)
Pain (153)
Pancreatic cancer (170)
Parkinson's disease (260)
Partnered (33)
Patents (397)
Patient recruitment (423)
Peanut (57)
People (66302)
Pharmaceutical (133)
Pharmacy benefit managers (20)
Phase 1 (23607)
Phase 2 (33141)
Phase 3 (24820)
Pipeline (4373)
Policy (283)
Postmarket research (3544)
Preclinical (10591)
Press Release (72)
Prostate cancer (205)
Psychedelics (52)
Radiopharmaceuticals (279)
Rare diseases (803)
Real estate (7423)
Recruiting (81)
Regulatory (28257)
Reports (63)
Research institute (2696)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (21)
RSV (63)
Schizophrenia (139)
Series A (225)
Series B (166)
Service/supplier (25)
Sickle cell disease (85)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4325)
State (2)
Stomach cancer (14)
Supply chain (74)
Tariffs (76)
The Weekly (123)
Vaccines (1008)
Venture capital (92)
Weight loss (341)
Women's health (73)
Worklife (22)
Date
Today (116)
Last 7 days (491)
Last 30 days (1802)
Last 365 days (25369)
2026 (2635)
2025 (25543)
2024 (34032)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (85)
Alaska (6)
Arizona (289)
Arkansas (8)
Asia (51140)
Australia (9003)
California (9770)
Canada (2487)
China (1066)
Colorado (307)
Connecticut (391)
Delaware (296)
Europe (116947)
Florida (1263)
Georgia (253)
Hawaii (4)
Idaho (65)
Illinois (653)
India (58)
Indiana (448)
Iowa (21)
Japan (344)
Kansas (133)
Kentucky (25)
Louisiana (14)
Maine (59)
Maryland (1261)
Massachusetts (7352)
Michigan (244)
Minnesota (453)
Mississippi (5)
Missouri (79)
Montana (29)
Nebraska (29)
Nevada (106)
New Hampshire (57)
New Jersey (2564)
New Mexico (29)
New York (2562)
North Carolina (1419)
North Dakota (9)
Northern California (4801)
Ohio (258)
Oklahoma (18)
Oregon (51)
Pennsylvania (1881)
Puerto Rico (23)
Rhode Island (33)
South America (1658)
South Carolina (13)
South Dakota (1)
Southern California (3770)
Tennessee (58)
Texas (1371)
United States (33958)
Utah (210)
Vermont (1)
Virginia (169)
Washington D.C. (54)
Washington State (818)
West Virginia (2)
Wisconsin (83)
858,528 Results for "nuvation bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nuvation Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
·
1 min read
Press Releases
Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma
February 10, 2026
·
6 min read
Press Releases
Nuvation Bio to Participate in Upcoming December 2025 Investor Conferences
November 27, 2025
·
1 min read
Press Releases
Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan
January 12, 2026
·
13 min read
Press Releases
Nuvation Bio to Participate in Upcoming Investor Conferences - October 30, 2025
October 31, 2025
·
1 min read
Press Releases
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
November 3, 2025
·
19 min read
Press Releases
Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
·
14 min read
Press Releases
Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology
December 3, 2025
·
7 min read
Press Releases
Nuvation Bio to Participate in Upcoming September 2025 Investor Conferences
August 28, 2025
·
1 min read
Lung cancer
Nuvation Scores First FDA Nod With Oral Lung Cancer Drug
Nuvation Bio’s first approved product is Ibtrozi, a CNS-active ROS1 inhibitor that in pivotal studies showed high rates of treatment response in patients with non-small cell lung cancer.
June 12, 2025
·
2 min read
·
Tristan Manalac
1 of 85,853
Next
